Our goal, with your help, is to find a cure childhood cancer and related blood disorders by providing critical funding for research.

The MACC Fund gives the Gift of Hope through Research.

Every penny counts. Every donation matters. Why? Because every child battling cancer or a blood disorder is someone's child, someone's sibling, someone's friend. Every donation gives hope to a child fighting cancer or a blood disorder.

Our goal is to fulfill the mission and to cure the MACC Fund out of existence.


MACC Fund supported research has had a significant impact. The five-year survival rate for all types of childhood cancer has risen to 80%. Thanks to our generous donors, participants, and volunteers, the MACC Fund has contributed $42 million to childhood cancer and related blood disorder research.

Your support of critical research impacts children throughout the country and the world. Successful protocols developed in Wisconsin have become the standard for patient care across the United States.

The MACC Fund supports research at the Medical College of Wisconsin in the MACC Fund Research Center.

In June 2008, the MACC Fund committed $5 million dollars to Children's Hospital to support translational research. Translational research is conducted at the MACC Fund Center for Cancer and Blood Disorders at Children's Hospital of Wisconsin.

Translational research takes discoveries from bench-to-bedside by bringing cutting edge research directly to patients.

The MACC Fund also supports research at the University of Wisconsin's Carbone Cancer Center where research is conducted in the MACC Fund Pediatric Cancer Research Wing at the Wisconsin Institutes for Medical Research in Madison, Wisconsin.

Ensuring the Institutional Mission

The Scientific Review Board

The MACC Fund Scientific Review Board was established in 1980 to reinforce and ensure our institutional mission. The Scientific Review Board carefully evaluates the work of the researchers and clinicians. It also reviews grant applications submitted for research conducted outside of the MACC Fund's primary beneficiary locations.

The Board is made up of leading pediatric oncology and hematology practitioners from around the country. Biennially, a site review of the research facilities is conducted.

The current review board members are:

Dr. Susan Blaney – Deputy Director, Texas Children's Cancer Center and Hematology Service; Director, Neuro-oncology Program and Clinical Pharmacology Program, Texas Children's Cancer Center and Hematology Service; Professor, Department of Pediatrics, Hematology/Oncology Section, Baylor College of Medicine

Stella Davies - Director of Division of Bone Marrow Transplantation and Immune Deficiency; Jacob G. Schmidlapp Endowed Chair; and Professor of Pediatrics at Cincinnati Children's Hospital Medical Center

Dr. Crystal Mackall – Director of Pediatric Oncology for the National Cancer Institute of the National Institutes of Health

Russell Ware - Chair, Department of Hematology; Lemuel Diggs Endowed Chair in Sickle Cell Disease; and Professor at St. Jude's Children's Hospital

Giving hope through research to children with cancer and blood disorders.